It is a potent inhibitor of the hub kinase GSK‐3β, whose β isoform (GSK‐3β) is involved in the development of a plethora of illnesses, including mood disorders (e.g., bipolar disorder), neurodegenerative diseases (e.g., tauopathies and Alzheimer's disease), and virus‐dependent infectious diseases (HSV‐1 infection, coronaviruses ‐e.g., SARS‐CoV‐1 and SARS‐CoV‐2‐mediated infections, etc.).[18] Indeed, its therapeutic effects in mood disorders,[54] viral infections,[18] and neurodegenerative diseases[55] have been extensively recognized. This evidence concerns the gene GSK3B and early-onset autosomal dominant Alzheimer disease.